There is evidence suggesting that HRT might slightly increase the risk of ovarian cancer, although the absolute risk remains small. For endometrial cancer, the risk is more closely associated with estrogen-only HRT in women who still have a uterus. Adding progesterone to the regimen mitigates this risk.
